FORGOT YOUR DETAILS?

AIMS Awards – Deadline April 29, 2019

Thursday, 25 April 2019 by

Artificial Intelligence Molecular Screen (AIMS) Awards program by Atomwise for academic researchers seeking novel compounds to treat disease. The goal of AIMS program is to broaden the pool of scientists involved in the discovery of small molecules for the treatment and investigation of human diseases. To advance this goal, Atomwise seeks proposals from innovative university

This Funding Opportunity Announcement (FOA) solicits applications to participate in an International Centers of Excellence for Malaria Research (ICEMR) program that will provide a multidisciplinary research approach to malaria control and prevention through the integration of findings from clinical and field research.  The overarching goal of the ICEMR program is to establish research centers in

The Bill & Melinda Gates Foundation and its funding partners in the Grand Challenges family of grant programs are inviting innovators to apply for this grant opportunity: Grand Challenges China: New Interventions for Global Health. This challenge focuses on calls for innovative concepts for safe, effective, affordable and widely utilized interventions, such as vaccines and

UC Berkeley Center for Global Public Health (CGPH) and the Center for Emerging & Neglected Diseases (CEND) are partnering up to provide students with an opportunity to attend this year’s Consortium of Universities for Global Health (CUGH) Conference for free! The conference will be held on April 9-11, 2016 in San Francisco. We are excited to offer

The purpose of this FOA is to solicit applications to support early stage translational research focused on the discovery and development of novel therapeutics against select eukaryotic pathogens. Application deadline: Feb 10, 2016 For more information and application instructions, please visit: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-054.html

The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research on innate and adaptive immune responses induced by mycobacterial infection, Bacillus Calmette-Guérin vaccine (BCG), or otherMycobacterium tuberculosis (Mtb) vaccinations.  Studies that include evaluation of immune responses by anatomical location in HIV-infected or uninfected individuals are of particular interest.  A secondary objective of

This joint National Institutes of Health (NIH) – National Science Foundation (NSF) initiative supports efforts to understand the underlying ecological and biological mechanisms that govern relationships between human-induced environmental changes and the emergence and transmission of infectious diseases. The highly interdisciplinary research projects funded under this program apply both ecological and biomedical methods, and study

Nov 11, 2015: Grand Challenges Explorations

Wednesday, 02 September 2015 by

Grand Challenges Explorations is seeking innovative global health and development solutions and is now accepting proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations, and for-profit companies. Initial grants will be US $100,000 each,

The Bill & Melinda Gates Foundation is launching a new Grand Challenge: Innovations in Vaccine Manufacturing for Global Markets. This challenge focuses on innovations in vaccine manufacturing platforms designed to lower production cost for vaccines that target diseases of great global burden and that are among the most costly to produce with current technologies. Deadline:

Faculty Travel Awards Program Summary The NIH-funded MHIRT program trains UC Berkeley and other qualified Bay Area students in infectious disease research, by funding short-term research experiences outside the U.S. for undergraduate or doctoral students. Each year , the grant provide 2-3 months of support for up to 10 student research projects, to be conducted at a site in

TOP UA-36873340-1